RecruitingNot ApplicableNCT07273136

Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural Analgesia in Patients Undergoing Major Abdominal Cancer Surgery

Safety and Efficacy of Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural Analgesia in Patients Undergoing Major Abdominal Cancer Surgery


Sponsor

Assiut University

Enrollment

50 participants

Start Date

Dec 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the safety and efficacy of combined subcostal and lateral transversus abdominis plane (TAP) for postoperative analgesia versus thoracic epidural anesthesia (TEA) in patients undergoing major abdominal cancer surgery.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥ 18 years.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Scheduled for major abdominal surgeries including: (e.g., gastrectomy, colectomy, hepatectomy, cystectomy, total abdominal hysterectomy, Nephrectomy, pancreatectomy).

Exclusion Criteria8

  • Intraoperative hemodynamic instability.
  • History or evidence of coagulopathy.
  • Infection or abdominal wall masses at injection site.
  • Morbid obesity.
  • Other Medical conditions including mental illness or substance abuse.
  • Known allergy to local anesthetics.
  • Chronic opioid use or chronic pain conditions.
  • Pregnancy.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSubcostal and lateral transversus abdominis plane block

Patients will receive an ultrasound-guided combined subcostal and lateral transversus abdominis plane block.

OTHERThoracic epidural anesthesia

Patients will receive an ultrasound-guided thoracic epidural anesthesia.


Locations(1)

Assiut University

Asyut, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07273136


Related Trials